Pharmacology Cardiovascular system fa2fdb0b All of the following statements about nasiritide are true except: A It is a BNP analogue B It can be used in decompensated CHF C It can be administered orally D It causes loss of Na+ in the urine High-Yield Explanation Ref:CMTD 2014/936;KDT 6/e p507 Nesiritide is a recombinant BNP It reduces vasodilation and natriuresis it has to be administered by i.v. route.